Apolipoprotein E4 genotype is not a risk factor for systemic AA amyloidosis or familial amyloid polyneuropathy
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Amyloid
- Vol. 2 (3) , 163-166
- https://doi.org/10.3109/13506129509036920
Abstract
Apolipoprotein E (apoE) is present in the amyloid deposits in Alzheimer's disease (AD) and in acquired and hereditary systemic amyloidosis, and apoE genotype is an important risk factor for late onset AD. In order to determine whether it is also a risk factor for developing reactive systemic amyloid A protein (AA) amyloidosis or transthyretin (TTR) Met 30 familial amyloid polyneuropathy (FAP), apoE genotype was determined in 32 patients with AA amyloid and 31 patients with FAP. Prevalence of the apoE ε4 allele was not significantly different than in a normal population. There was also no correlation between apoE genotype and either the time from presentation of the underlying disease to the diagnosis of AA amyloid or the age of onset of symptoms in FAP. These results suggest that apoE genotype does not affect susceptibility to or expression of AA amyloidosis or TTR Met 30 FAP.Keywords
This publication has 13 references indexed in Scilit:
- Is Alzheimer's disease an apolipoprotein E amyloidosis?The Lancet, 1995
- Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filamentsNature, 1994
- Transthyretin sequesters amyloid beta protein and prevents amyloid formation.Proceedings of the National Academy of Sciences, 1994
- Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.Journal of Clinical Investigation, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloidNeuroscience Letters, 1992
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967